COVID-19
COVID-19
Cost Effective Process Technology of Favipiravir Developed by CSIR Used by M/s Cipla Ltd.
IMF Raised Issue of Limiting COVID-19 Pandemic's Scarring Effects on Women
Glenmark Announces Results of Phase 3 Clinical Trial of Favipiravir on COVID Patients
CEA Krishnamurthy Hinted at Fresh Economic Stimulus Once Covid Eases
/smstreet/media/agency_attachments/3LWGA69AjH55EG7xRGSA.png)
/smstreet/media/post_banners/CrT7a0IJyGg7VhOVF2bV.jpg)
/smstreet/media/post_banners/ll0X7b2qDwVeKjiVREVN.jpg)
/smstreet/media/post_banners/xHAUf9dmEopIKeFz8LGg.jpg)
/smstreet/media/post_banners/XR8DACmcJPhB9O7IXZtp.png)
/smstreet/media/post_banners/mw5HNXq2M6lRaFe1lfZT.jpg)
/smstreet/media/post_banners/dCT1mEh2MX7CtKGu8czb.jpg)
/smstreet/media/post_banners/RsBrNSckDwizvYFUlXTP.jpeg)
/smstreet/media/post_banners/J8DvVZI9iEw55A6lOv4y.jpg)
/smstreet/media/post_banners/BtMqFPKcDwTyO19RusaX.jpg)
/smstreet/media/post_banners/q6sPS9gk36bMWRqMEkfl.jpg)
